Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

INTRODUCTION: In December 2019, an outbreak of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began, resulting in a number of antivirals and immune modulators being repurposed to treat the associated coronavirus disease 2019 (COVID-19). Many patients requiring treatment for COV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs R D
Main Authors: Marra, Fiona, Smolders, Elise J., El-Sherif, Omar, Boyle, Alison, Davidson, Katherine, Sommerville, Andrew J., Marzolini, Catia, Siccardi, Marco, Burger, David, Gibbons, Sara, Khoo, Saye, Back, David
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7745756/
https://ncbi.nlm.nih.gov/pubmed/33336316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-020-00333-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados